Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis

Virchows Archiv

Volumn 448, Issue 4, 2006, Pages 412-421

  Jinno, Yoshio ^a,d   Ohtani, Haruo ^b,c   Nakamura, Shiro ^a   Oki, Motoji ^c   Maeda, Kiyoshi ^a   Fukushima, Kohei ^c   Nagura, Hiroshi ^c   Oshitani, Nobuhide ^a   Matsumoto, Takayuki ^a,d   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

B lineage cells; Ki 67; Plasma cells; Ulcerative colitis

Indexed keywords

CD19 ANTIGEN; CD20 ANTIBODY; CORTICOSTEROID; KI 67 ANTIGEN; SYNDECAN 1;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CELL LINEAGE; CLINICAL ARTICLE; CROHN DISEASE; CYTOPLASM; DISEASE ACTIVITY; ENDOPLASMIC RETICULUM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PATIENT; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; ULCER; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD19; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL LINEAGE; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG RESISTANCE; ENDOPLASMIC RETICULUM; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLASMA CELLS;

EID: 33645577197     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0136-7     Document Type: Article

References (25)

1. Baldassano RN, Schreiber S, Johnston RB Jr, Fu RD, Muraki T, MacDermott RP (1993) Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 105:60-66
2. Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253-300
3. Bull DM, Bookman MA (1977) Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 59: 966-974
4. Cario E (2005) Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2. Gut 54:1182-1193
5. Das KM, Dubin R, Nagai T (1978) Isolation and characterization of colonic tissue-bound antibodies from patients with idiopathic ulcerative colitis. Proc Natl Acad Sci U S A 74:4523-4532
6. Fell JME, Walker-Smith JA, Spencer J, Macdonald TT (1996) The distribution of dividing T cells throughout the intestinal wall in inflammatory bowel disease. Clin Exp Immunol 104:280-285
7. Fiocchi C (1985) Lymphoid cells of the gastrointestinal tract. Isolation procedures. Acta Chir Scand Suppl 525: 11-23
8. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873
9. Halstensen TS, Das KM, Brandtzaeg P (1993) Epithelial deposits of immunoglobulin G1 and activated complement colocalise with 40kD putative autoantigen in ulcerative colitis. Gut 34:650-657
10. Iatropoulos MJ, Williams GM (1996) Proliferation markers. Exp Toxicol Pathol 48:175-181
11. Kawachiya T, Oshitani N, Jinno Y, Watanabe K, Nakamura S, Fujiwara Y, Higuchi K, Maeda K, Nishiguchi Y, Hirakawa K, Matsumoto T, Arakawa T (2005) Significance of increased proliferation of immature plasma cells in the appendix of patients with ulcerative colitis. Int J Mol Med 15:417-423
12. Kullmann F, Fadale M, Gross V, Knuchel R, Bocker T, Steinbach P, Scholmerich J, Ruschoff J (1996) Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease. Eur J Gastroenterol Hepatol 8:371-379
13. Leonard JP, Schattner EJ, Coleman M (2001) Biology and management of mantle cell lymphoma. Curr Opin Oncol 13:342-347
14. MacLennan I, Vinuesa C (2002) Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17:235-238
15. Meinzer U, Hugot JP (2005) NOD2 and Crohn's disease: many connected highways. Lancet 365:1752-1754
16. Monteleone I, Vavassori P, Biancone L, Monteleone G, Pallone F (2002) Immunoregulation in the gut: success and failures in human disease. Gut 50(Suppl 3):III60-64
17. Nagler-Anderson C (2001) Man the barrier! Strategic defenses in the intestinal mucosa. Nat Rev Immunol 1:59-67
18. Saiki Y, Ohtani H, Naito Y, Miyazawa M, Nagura H (1996) Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. Lab Invest 75:67-76
19. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M (1992) An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87:971-976
20. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I (2002) Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123:450-460
21. Truelove SC, Witts LJ (1959) Cortisone and corticotrophin in ulcerative colitis. Br Med J 14:387-394
22. Tsujikawa T, Satoh J, Uda K, Ihara T, Okamoto T, Araki Y, Sasaki M, Fujiyama Y, Bamba T (2000) Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. J Gastroenterol 35:99-104
23. Wijdenes J, Dore JM, Clement C, Vermot-Desroches C (2002) CD138. J Biol Regul Homeost Agents 16:152-155
24. Yacyshyn BR (1993) Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis. Immunol Cell Biol 71:265-274
25. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C (1993) Localization of intestinal interleukin 1 activity and gene expression to lamina propria cells. Gastroenterology 104:749-758